Pulmonary immunity during respiratory infections in early life and the development of severe asthma

Annals of the American Thoracic Society

Volumn 11, Issue , 2014, Pages S297-S302

  Hansbro, Philip M ^a,c   Starkey, Malcolm R ^a   Mattes, Joerg ^a,b   Horvat, Jay C ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b Paediatric Respiratory and Sleep Medicine Unit   (Australia)

^c HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Asthma; Chlamydia; Early life; IL 13; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

ANTIGEN; BRONCHODILATING AGENT; CORTICOSTEROID; INTERLEUKIN 13; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; ALLERGEN; CYTOKINE;

ADULTHOOD; ALLERGIC AIRWAY DISEASE; ALLERGIC AIRWAY INFLAMMATION; ARTICLE; ASTHMA; BACTERIAL INFECTION; CHLAMYDIA; CHRONIC DISEASE; CHRONIC LUNG DISEASE; CYTOKINE RESPONSE; DISEASE SEVERITY; GENE DELETION; HISTOPATHOLOGY; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNE RESPONSE; IMMUNITY; INFECTION PREVENTION; INFECTION SENSITIVITY; INFLAMMATION; LUNG FUNCTION; LUNG STRUCTURE; MOUSE MODEL; MUCUS HYPERSECRETION; MYCOPLASMA; NEWBORN INFECTION; NONHUMAN; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; RHINOVIRUS; WEIGHT REDUCTION; AGE; ANIMAL; CELLULAR IMMUNITY; COMPLICATION; IMMUNOLOGY; LUNG; MOUSE; SEVERITY OF ILLNESS INDEX;

AGE FACTORS; ALLERGENS; ANIMALS; ASTHMA; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; LUNG; MICE; RESPIRATORY TRACT INFECTIONS; SEVERITY OF ILLNESS INDEX;

EID: 84919621465     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201402-086AW     Document Type: Article

References (58)

1. Schaub B, Lauener R, von Mutius E. The many faces of the hygiene hypothesis. J Allergy Clin Immunol 2006;117:969-977, quiz 978.
2. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001;1:69-75.
3. Strachan DP. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000;55:S2-S10.
4. George CL, White ML, Kulhankova K, Mahajan A, Thorne PS, Snyder JM, Kline JN. Early exposure to a nonhygienic environment alters pulmonary immunity and allergic responses. Am J Physiol Lung Cell Mol Physiol 2006;291:L512-L522.
5. Umetsu DT, McIntire JJ, Akbari O, Macaubas C, DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nat Immunol 2002;3: 715-720.
6. Hansbro PM, Beagley KW, Horvat JC, Gibson PG. Role of atypical bacterial infection of the lung in predisposition/protection of asthma. Pharmacol Ther 2004;101:193-210.
7. Openshaw PJ, Yamaguchi Y, Tregoning JS. Childhood infections, the developing immune system, and the origins of asthma. J Allergy Clin Immunol 2004;114:1275-1277.
8. Thorburn AN, Hansbro PM. Harnessing regulatory T cells to suppress asthma: from potential to therapy. Am J Respir Cell Mol Biol 2010;43: 511-519.
9. Culley FJ, Pollott J, Openshaw PJ. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J Exp Med 2002;196:1381-1386.
10. Prescott SL, Macaubas C, Holt BJ, Smallacombe TB, Loh R, Sly PD, Holt PG. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine pro file. J Immunol 1998;160:4730-4737.
11. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Loh R, Holt PG. Reciprocal age-related patterns of allergen-specific T-cell immunity in normal vs. atopic infants. Clin Exp Allergy 1998;28 5: 39-44; discussion 50 -51.
12. Hansbro NG, Horvat JC, Wark PA, Hansbro PM. Understanding the mechanisms of viral induced asthma: new therapeutic directions. Pharmacol Ther 2008;117:313-353.
13. Garcia AM, Fadel SA, Cao S, Sarzotti M. T cell immunity in neonates. Immunol Res 2000;22:177-190.
14. Adkins B, Bu Y, Guevara P. The generation of Th memory in neonates versus adults: prolonged primary Th2 effector function and impaired development of Th1 memory effector function in murine neonates. J Immunol 2001;166:918-925.
15. Kovarik J, Siegrist CA. Immunity in early life. Immunol Today 1998;19: 150-152.
16. Marodi L. Down-regulation of Th1 responses in human neonates. Clin Exp Immunol 2002;128:1-2.
17. Li R, Yang X, Wang L, Liu E. Respiratory syncytial virus infection reversed anti-asthma effect of neonatal bacillus Calmette-Guerin vaccination in BALB/c mice. Pediatr Res 2006;59:210-215.
18. Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C, Muller A. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 2011; 121:3088-3093.
19. Oertli M, Sundquist M, Hitzler I, Engler DB, Arnold IC, Reuter S, Maxeiner J, Hansson M, Taube C, Quiding-Jarbrink M, et al . DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylorispecific immune tolerance, and asthma protection. J Clin Invest 2012;122:1082-1096.
20. Preston JA, Thorburn AN, Starkey MR, Beckett EL, Horvat JC, Wade MA, O' Sullivan BJ, Thomas R, Beagley KW, Gibson PG, et al. Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T cells. Eur Respir J 2011;37: 53-64.
21. Preston JA, Essilfie AT, Horvat JC, Wade MA, Beagley KW, Gibson PG, Foster PS, Hansbro PM. Inhibition of allergic airways disease by immunomodulatory therapy with whole killed Streptococcus pneumoniae. Vaccine 2007;25:8154-8162.
22. Thorburn AN, O'Sullivan BJ, Thomas R, Kumar RK, Foster PS, Gibson PG, Hansbro PM. Pneumococcal conjugate vaccine-induced T regulatory cells suppress the development of allergic airways disease. Thorax 2010;65:1053-1060.
23. Thorburn AN, Foster PS, Gibson PG, Hansbro PM. Components of Streptococcus pneumoniae suppress allergic airways disease and natural killer T cells by inducing regulatory T cells. J Immunol 2012; 188:4611-4620.
24. Thorburn AN, Brown A, Monogar P, Chevalier N, Foster PS, Gibson PG, Hansbro PM. Pneumococcal components induce regulatory T cells that attenuate the development of allergic airways disease by deviating and suppressing the immune response to allergen. J Immunol 2013;191:4112-4120.
25. Burri PH. Fetal and postnatal development of the lung. Annu Rev Physiol 1984;46:617-628.
26. Beem MO, Saxon EM. Respiratory-tract colonization and a distinctive pneumonia syndrome in infants infected with Chlamydia trachomatis. N Engl J Med 1977;296:306-310.
27. Mardh PA, Helin I, Bobeck S, Laurin J, Nilsson T. Colonisation of pregnant and puerperal women and neonates with Chlamydia trachomatis. Br J Vener Dis 1980;56:96-100.
28. Hammerschlag MR. Pneumonia due to Chlamydia pneumoniae in children: epidemiology, diagnosis, and treatment. Pediatr Pulmonol 2003;36:384-390.
29. Hammerschlag MR. Chlamydia trachomatis and Chlamydia pneumoniae infections in children and adolescents. Pediatr Rev 2004;25:43-51.
30. Numazaki K, Chiba S, Kogawa K, Umetsu M, Motoya H, Nakao T. Chronic respiratory disease in premature infants caused by Chlamydia trachomatis. J Clin Pathol 1986;39:84-88.
31. Alexander ER, Harrison HR. Role of Chlamydia trachomatis in perinatal infection. Rev Infect Dis 1983;5:713-719.
32. Harrison HR, Taussig LM, Fulginiti VA. Chlamydia trachomatis and chronic respiratory disease in childhood. Pediatr Infect Dis 1982;1: 29-33.
33. Jupelli M, Guentzel MN, Meier PA, Zhong G, Murthy AK, Arulanandam BP. Endogenous IFN-gamma production is induced and required for protective immunity against pulmonary chlamydial infection in neonatal mice. J Immunol 2008;180:4148-4155.
34. Jupelli M, Selby DM, Guentzel MN, Chambers JP, Forsthuber TG, Zhong G, Murthy AK, Arulanandam BP. The contribution of interleukin-12/interferon-gamma axis in protection against neonatal pulmonary Chlamydia muridarum challenge. J Interferon Cytokine Res 2010;30:407-415.
35. Emre U, Sokolovskaya N, Roblin PM, Schachter J, Hammerschlag MR. Detection of anti- Chlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis 1995;172:265-267.
36. Hahn DL, Schure A, Patel K, Childs T, Drizik E, Webley W. Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity. PLoS ONE 2012;7:e35945.
37. Teig N, Anders A, Schmidt C, Rieger C, Gatermann S. Chlamydophila pneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases. Thorax 2005;60:962-966.
38. Webley WC, Salva PS, Andrzejewski C, Cirino F, West CA, Tilahun Y, Stuart ES. The bronchial lavage of pediatric patients with asthma contains infectious Chlamydia. Am J Respir Crit Care Med 2005;171:1083-1088.
39. Zaitsu M. The development of asthma in wheezing infants with Chlamydia pneumoniae infection. J Asthma 2007;44:565-568.
40. Horvat JC, Beagley KW, Wade MA, Preston JA, Hansbro NG, Hickey DK, Kaiko GE, Gibson PG, Foster PS, Hansbro PM. Neonatal chlamydial infection induces mixed T-cell responses that drive allergic airway disease. Am J Respir Crit Care Med 2007;176:556-564.
41. Horvat JC, Starkey MR, Kim RY, Phipps S, Gibson PG, Beagley KW, Foster PS, Hansbro PM. Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology. J Allergy Clin Immunol 2010;125: 617-625, 625.e1 -625.e6.
42. Jupelli M, Murthy AK, Chaganty BK, Guentzel MN, Selby DM, Vasquez MM, Mustafa SB, Henson BM, Seidner SR, Zhong G, et al. Neonatal Chlamydial pneumonia induces altered respiratory structure and function lasting into adult life. Lab Invest 2011;91:1530-1539.
43. Starkey MR, Essilfie AT, Horvat JC, Kim RY, Nguyen DH, Beagley KW, Mattes J, Foster PS, Hansbro PM. Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease. Mucosal Immunol 2013;6:569-579.
44. Starkey MR, Nguyen DH, Essilfie AT, Kim RY, Hatchwell LM, Collison AM, Yagita H, Foster PS, Horvat JC, Mattes J, et al. Tumor necrosis factor-related apoptosis- inducing ligand translates neonatal respiratory infection into chronic lung disease. Mucosal Immunol 2013;7:478-488.
45. Steinwede K, Henken S, Bohling J, Maus R, Ueberberg B, Brumshagen C, Brincks EL, Griffith TS, Welte T, Maus UA. TNF-related apoptosisinducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice. J Exp Med 2012; 209:1937-1952.
46. Brincks EL, Katewa A, Kucaba TA, Griffith TS, Legge KL. CD8 T cells utilize TRAIL to control influenza virus infection. J Immunol 2008;181: 4918-4925.
47. Ishikawa E, Nakazawa M, Yoshinari M, Minami M. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice. J Virol 2005;79: 7658-7663.
48. Asquith KL, Horvat JC, Kaiko GE, Carey AJ, Beagley KW, Hansbro PM, Foster PS. Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts. PLoS Pathog 2011;7: e1001339.
49. Kaiko GE, Phipps S, Hickey DK, Lam CE, Hansbro PM, Foster PS, Beagley KW. Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity. J Immunol 2008;180:2225-2232.
50. Weckmann M, Collison A, Simpson JL, Kopp MV, Wark PA, Smyth MJ, Yagita H, Matthaei KI, Hansbro N, Whitehead B, et al. Critical link between TRAIL and CCL20 for the activation of Th2 cells and the expression of allergic airway disease. Nat Med 2007;13:1308-1315.
51. Collison A, Hatchwell L, Verrills N, Wark PA, de Siqueira AP, Tooze M, Carpenter H, Don AS, Morris JC, Zimmermann N, et al. The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nat Med 2013; 19:232-237.
52. You D, Becnel D, Wang K, Ripple M, Daly M, Cormier SA. Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults. Respir Res 2006;7:107.
53. You D, Ripple M, Balakrishna S, Troxclair D, Sandquist D, Ding L, Ahlert TA, Cormier SA. Inchoate CD8+ T cell responses in neonatal mice permit influenza-induced persistent pulmonary dysfunction. J Immunol 2008;181:3486-3494.
54. Schneider D, Hong JY, Popova AP, Bowman ER, Linn MJ, McLean AM, Zhao Y, Sonstein J, Bentley JK, Weinberg JB, et al. Neonatal rhinovirus infection induces mucous metaplasia and airways hyperresponsiveness. J Immunol 2012;188:2894-2904.
55. Tekkanat KK, Maassab HF, Cho DS, Lai JJ, John A, Berlin A, Kaplan MH, Lukacs NW. IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is Stat6 dependent. J Immunol 2001;166:3542-3548.
56. Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE, Dekruyff RH, Umetsu DT. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011;12:631-638.
57. Lukacs NW, Tekkanat KK, Berlin A, Hogaboam CM, Miller A, Evanoff H, Lincoln P, Maassab H. Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms. J Immunol 2001;167:1060-1065.
58. Beckett EL, Phipps S, Starkey MR, Horvat JC, Beagley KW, Foster PS, Hansbro PM. TLR2, but not TLR4, is required for effective host defence against Chlamydia respiratory tract infection in early life. PLoS ONE 2012;7:e39460.